Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase
β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and cephalosporins. Transition-state analogues that bind to the enzymes with nanomolar affinities have been introduced in an effort to reverse the resistance conferred by these enzymes. To unde...
Gespeichert in:
Veröffentlicht in: | Biochemistry (Easton) 2003-12, Vol.42 (49), p.14483-14491 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 14491 |
---|---|
container_issue | 49 |
container_start_page | 14483 |
container_title | Biochemistry (Easton) |
container_volume | 42 |
creator | Roth, Tomer A Minasov, George Morandi, Stefania Prati, Fabio Shoichet, Brian K |
description | β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and cephalosporins. Transition-state analogues that bind to the enzymes with nanomolar affinities have been introduced in an effort to reverse the resistance conferred by these enzymes. To understand the origins of this affinity, and to guide design of future inhibitors, double-mutant thermodynamic cycle experiments were undertaken. An unexpected hydrogen bond between the nonconserved Asn289 and a key inhibitor carboxylate was observed in the X-ray crystal structure of a 1 nM inhibitor (compound 1) in complex with AmpC β-lactamase. To investigate the energy of this hydrogen bond, the mutant enzyme N289A was made, as was an analogue of 1 that lacked the carboxylate (compound 2). The differential affinity of the four different protein and analogue complexes indicates that the carboxylate−amide hydrogen bond contributes 1.7 kcal/mol to overall binding affinity. Synthesis of an analogue of 1 where the carboxylate was replaced with an aldehyde led to an inhibitor that lost all this hydrogen bond energy, consistent with the importance of the ionic nature of this hydrogen bond. To investigate the structural bases of these energies, X-ray crystal structures of N289A/1 and N289A/2 were determined to 1.49 and 1.39 Å, respectively. These structures suggest that no significant rearrangement occurs in the mutant versus the wild-type complexes with both compounds. The mutant enzymes L119A and L293A were made to investigate the interaction between a phenyl ring in 1 and these residues. Whereas deletion of the phenyl itself diminishes affinity by 5-fold, the double-mutant cycles suggest that this energy does not come through interaction with the leucines, despite the close contact in the structure. The energies of these interactions provide key information for the design of improved inhibitors against β-lactamases. The high magnitude of the ion−dipole interaction between Asn289 and the carboxylate of 1 is consistent with the idea that ionic interactions can provide significant net affinity in inhibitor complexes. |
doi_str_mv | 10.1021/bi035054a |
format | Article |
fullrecord | <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_bi035054a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_TPS_XQVJ6M8K_7</sourcerecordid><originalsourceid>FETCH-LOGICAL-a349t-95a7e7db3f0ee891cb3588672a1be824ef222d93cc9f52260e266141d72516f73</originalsourceid><addsrcrecordid>eNptkMtOwzAQRS0EoqWw4AdQNixYBGzHj2QJ5dFCESAKYmdNHKd1aZLKTiXy96RKVTasRjNzNPfOReiU4EuCKblKLY445gz2UJ9wikOWJHwf9THGIqSJwD105P2ibRmW7BD1CBOCtPM-Gk3nxhVV1pRQWB0MG700wXUJy8ZbH0CZBeNyblNbVy64Nd7OygBmYEtfBzemhnACuoYCvDlGBzksvTnZ1gH6uL-bDkfh5OVhPLyehBCxpA4TDtLILI1ybEycEJ1GPI6FpEBSE1NmckpplkRaJzmnVGBDW6uMZJJyInIZDdBFd1e7yntncrVytgDXKILVJg21S6Nlzzp2tU4Lk_2R2_dbIOwA62vzs9uD-1ZCRpKr6eu7-nr7fBTP8ZPaiJ93PGivFtXatUH5f4R_AZN8dFM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase</title><source>MEDLINE</source><source>ACS Publications</source><creator>Roth, Tomer A ; Minasov, George ; Morandi, Stefania ; Prati, Fabio ; Shoichet, Brian K</creator><creatorcontrib>Roth, Tomer A ; Minasov, George ; Morandi, Stefania ; Prati, Fabio ; Shoichet, Brian K</creatorcontrib><description>β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and cephalosporins. Transition-state analogues that bind to the enzymes with nanomolar affinities have been introduced in an effort to reverse the resistance conferred by these enzymes. To understand the origins of this affinity, and to guide design of future inhibitors, double-mutant thermodynamic cycle experiments were undertaken. An unexpected hydrogen bond between the nonconserved Asn289 and a key inhibitor carboxylate was observed in the X-ray crystal structure of a 1 nM inhibitor (compound 1) in complex with AmpC β-lactamase. To investigate the energy of this hydrogen bond, the mutant enzyme N289A was made, as was an analogue of 1 that lacked the carboxylate (compound 2). The differential affinity of the four different protein and analogue complexes indicates that the carboxylate−amide hydrogen bond contributes 1.7 kcal/mol to overall binding affinity. Synthesis of an analogue of 1 where the carboxylate was replaced with an aldehyde led to an inhibitor that lost all this hydrogen bond energy, consistent with the importance of the ionic nature of this hydrogen bond. To investigate the structural bases of these energies, X-ray crystal structures of N289A/1 and N289A/2 were determined to 1.49 and 1.39 Å, respectively. These structures suggest that no significant rearrangement occurs in the mutant versus the wild-type complexes with both compounds. The mutant enzymes L119A and L293A were made to investigate the interaction between a phenyl ring in 1 and these residues. Whereas deletion of the phenyl itself diminishes affinity by 5-fold, the double-mutant cycles suggest that this energy does not come through interaction with the leucines, despite the close contact in the structure. The energies of these interactions provide key information for the design of improved inhibitors against β-lactamases. The high magnitude of the ion−dipole interaction between Asn289 and the carboxylate of 1 is consistent with the idea that ionic interactions can provide significant net affinity in inhibitor complexes.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi035054a</identifier><identifier>PMID: 14661960</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Alanine - genetics ; Asparagine - genetics ; Bacterial Proteins ; beta-Lactamase Inhibitors ; beta-Lactamases - chemistry ; beta-Lactamases - genetics ; Binding Sites ; Crystallization ; Crystallography, X-Ray ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - chemistry ; Escherichia coli Proteins - antagonists & inhibitors ; Escherichia coli Proteins - chemistry ; Escherichia coli Proteins - genetics ; Hydrogen Bonding ; Leucine - genetics ; Mutagenesis, Site-Directed ; Nuclear Magnetic Resonance, Biomolecular ; Protein Binding ; Recombinant Proteins - antagonists & inhibitors ; Recombinant Proteins - chemical synthesis ; Recombinant Proteins - genetics ; Thermodynamics</subject><ispartof>Biochemistry (Easton), 2003-12, Vol.42 (49), p.14483-14491</ispartof><rights>Copyright © 2003 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a349t-95a7e7db3f0ee891cb3588672a1be824ef222d93cc9f52260e266141d72516f73</citedby><cites>FETCH-LOGICAL-a349t-95a7e7db3f0ee891cb3588672a1be824ef222d93cc9f52260e266141d72516f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi035054a$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi035054a$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2751,27055,27903,27904,56716,56766</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14661960$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roth, Tomer A</creatorcontrib><creatorcontrib>Minasov, George</creatorcontrib><creatorcontrib>Morandi, Stefania</creatorcontrib><creatorcontrib>Prati, Fabio</creatorcontrib><creatorcontrib>Shoichet, Brian K</creatorcontrib><title>Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and cephalosporins. Transition-state analogues that bind to the enzymes with nanomolar affinities have been introduced in an effort to reverse the resistance conferred by these enzymes. To understand the origins of this affinity, and to guide design of future inhibitors, double-mutant thermodynamic cycle experiments were undertaken. An unexpected hydrogen bond between the nonconserved Asn289 and a key inhibitor carboxylate was observed in the X-ray crystal structure of a 1 nM inhibitor (compound 1) in complex with AmpC β-lactamase. To investigate the energy of this hydrogen bond, the mutant enzyme N289A was made, as was an analogue of 1 that lacked the carboxylate (compound 2). The differential affinity of the four different protein and analogue complexes indicates that the carboxylate−amide hydrogen bond contributes 1.7 kcal/mol to overall binding affinity. Synthesis of an analogue of 1 where the carboxylate was replaced with an aldehyde led to an inhibitor that lost all this hydrogen bond energy, consistent with the importance of the ionic nature of this hydrogen bond. To investigate the structural bases of these energies, X-ray crystal structures of N289A/1 and N289A/2 were determined to 1.49 and 1.39 Å, respectively. These structures suggest that no significant rearrangement occurs in the mutant versus the wild-type complexes with both compounds. The mutant enzymes L119A and L293A were made to investigate the interaction between a phenyl ring in 1 and these residues. Whereas deletion of the phenyl itself diminishes affinity by 5-fold, the double-mutant cycles suggest that this energy does not come through interaction with the leucines, despite the close contact in the structure. The energies of these interactions provide key information for the design of improved inhibitors against β-lactamases. The high magnitude of the ion−dipole interaction between Asn289 and the carboxylate of 1 is consistent with the idea that ionic interactions can provide significant net affinity in inhibitor complexes.</description><subject>Alanine - genetics</subject><subject>Asparagine - genetics</subject><subject>Bacterial Proteins</subject><subject>beta-Lactamase Inhibitors</subject><subject>beta-Lactamases - chemistry</subject><subject>beta-Lactamases - genetics</subject><subject>Binding Sites</subject><subject>Crystallization</subject><subject>Crystallography, X-Ray</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Escherichia coli Proteins - antagonists & inhibitors</subject><subject>Escherichia coli Proteins - chemistry</subject><subject>Escherichia coli Proteins - genetics</subject><subject>Hydrogen Bonding</subject><subject>Leucine - genetics</subject><subject>Mutagenesis, Site-Directed</subject><subject>Nuclear Magnetic Resonance, Biomolecular</subject><subject>Protein Binding</subject><subject>Recombinant Proteins - antagonists & inhibitors</subject><subject>Recombinant Proteins - chemical synthesis</subject><subject>Recombinant Proteins - genetics</subject><subject>Thermodynamics</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkMtOwzAQRS0EoqWw4AdQNixYBGzHj2QJ5dFCESAKYmdNHKd1aZLKTiXy96RKVTasRjNzNPfOReiU4EuCKblKLY445gz2UJ9wikOWJHwf9THGIqSJwD105P2ibRmW7BD1CBOCtPM-Gk3nxhVV1pRQWB0MG700wXUJy8ZbH0CZBeNyblNbVy64Nd7OygBmYEtfBzemhnACuoYCvDlGBzksvTnZ1gH6uL-bDkfh5OVhPLyehBCxpA4TDtLILI1ybEycEJ1GPI6FpEBSE1NmckpplkRaJzmnVGBDW6uMZJJyInIZDdBFd1e7yntncrVytgDXKILVJg21S6Nlzzp2tU4Lk_2R2_dbIOwA62vzs9uD-1ZCRpKr6eu7-nr7fBTP8ZPaiJ93PGivFtXatUH5f4R_AZN8dFM</recordid><startdate>20031216</startdate><enddate>20031216</enddate><creator>Roth, Tomer A</creator><creator>Minasov, George</creator><creator>Morandi, Stefania</creator><creator>Prati, Fabio</creator><creator>Shoichet, Brian K</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20031216</creationdate><title>Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase</title><author>Roth, Tomer A ; Minasov, George ; Morandi, Stefania ; Prati, Fabio ; Shoichet, Brian K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a349t-95a7e7db3f0ee891cb3588672a1be824ef222d93cc9f52260e266141d72516f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Alanine - genetics</topic><topic>Asparagine - genetics</topic><topic>Bacterial Proteins</topic><topic>beta-Lactamase Inhibitors</topic><topic>beta-Lactamases - chemistry</topic><topic>beta-Lactamases - genetics</topic><topic>Binding Sites</topic><topic>Crystallization</topic><topic>Crystallography, X-Ray</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Escherichia coli Proteins - antagonists & inhibitors</topic><topic>Escherichia coli Proteins - chemistry</topic><topic>Escherichia coli Proteins - genetics</topic><topic>Hydrogen Bonding</topic><topic>Leucine - genetics</topic><topic>Mutagenesis, Site-Directed</topic><topic>Nuclear Magnetic Resonance, Biomolecular</topic><topic>Protein Binding</topic><topic>Recombinant Proteins - antagonists & inhibitors</topic><topic>Recombinant Proteins - chemical synthesis</topic><topic>Recombinant Proteins - genetics</topic><topic>Thermodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roth, Tomer A</creatorcontrib><creatorcontrib>Minasov, George</creatorcontrib><creatorcontrib>Morandi, Stefania</creatorcontrib><creatorcontrib>Prati, Fabio</creatorcontrib><creatorcontrib>Shoichet, Brian K</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roth, Tomer A</au><au>Minasov, George</au><au>Morandi, Stefania</au><au>Prati, Fabio</au><au>Shoichet, Brian K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>2003-12-16</date><risdate>2003</risdate><volume>42</volume><issue>49</issue><spage>14483</spage><epage>14491</epage><pages>14483-14491</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and cephalosporins. Transition-state analogues that bind to the enzymes with nanomolar affinities have been introduced in an effort to reverse the resistance conferred by these enzymes. To understand the origins of this affinity, and to guide design of future inhibitors, double-mutant thermodynamic cycle experiments were undertaken. An unexpected hydrogen bond between the nonconserved Asn289 and a key inhibitor carboxylate was observed in the X-ray crystal structure of a 1 nM inhibitor (compound 1) in complex with AmpC β-lactamase. To investigate the energy of this hydrogen bond, the mutant enzyme N289A was made, as was an analogue of 1 that lacked the carboxylate (compound 2). The differential affinity of the four different protein and analogue complexes indicates that the carboxylate−amide hydrogen bond contributes 1.7 kcal/mol to overall binding affinity. Synthesis of an analogue of 1 where the carboxylate was replaced with an aldehyde led to an inhibitor that lost all this hydrogen bond energy, consistent with the importance of the ionic nature of this hydrogen bond. To investigate the structural bases of these energies, X-ray crystal structures of N289A/1 and N289A/2 were determined to 1.49 and 1.39 Å, respectively. These structures suggest that no significant rearrangement occurs in the mutant versus the wild-type complexes with both compounds. The mutant enzymes L119A and L293A were made to investigate the interaction between a phenyl ring in 1 and these residues. Whereas deletion of the phenyl itself diminishes affinity by 5-fold, the double-mutant cycles suggest that this energy does not come through interaction with the leucines, despite the close contact in the structure. The energies of these interactions provide key information for the design of improved inhibitors against β-lactamases. The high magnitude of the ion−dipole interaction between Asn289 and the carboxylate of 1 is consistent with the idea that ionic interactions can provide significant net affinity in inhibitor complexes.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>14661960</pmid><doi>10.1021/bi035054a</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-2960 |
ispartof | Biochemistry (Easton), 2003-12, Vol.42 (49), p.14483-14491 |
issn | 0006-2960 1520-4995 |
language | eng |
recordid | cdi_crossref_primary_10_1021_bi035054a |
source | MEDLINE; ACS Publications |
subjects | Alanine - genetics Asparagine - genetics Bacterial Proteins beta-Lactamase Inhibitors beta-Lactamases - chemistry beta-Lactamases - genetics Binding Sites Crystallization Crystallography, X-Ray Enzyme Inhibitors - chemical synthesis Enzyme Inhibitors - chemistry Escherichia coli Proteins - antagonists & inhibitors Escherichia coli Proteins - chemistry Escherichia coli Proteins - genetics Hydrogen Bonding Leucine - genetics Mutagenesis, Site-Directed Nuclear Magnetic Resonance, Biomolecular Protein Binding Recombinant Proteins - antagonists & inhibitors Recombinant Proteins - chemical synthesis Recombinant Proteins - genetics Thermodynamics |
title | Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T13%3A17%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thermodynamic%20Cycle%20Analysis%20and%20Inhibitor%20Design%20against%20Beta-Lactamase&rft.jtitle=Biochemistry%20(Easton)&rft.au=Roth,%20Tomer%20A&rft.date=2003-12-16&rft.volume=42&rft.issue=49&rft.spage=14483&rft.epage=14491&rft.pages=14483-14491&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi035054a&rft_dat=%3Cistex_cross%3Eark_67375_TPS_XQVJ6M8K_7%3C/istex_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/14661960&rfr_iscdi=true |